Association studies for asthma and atopic diseases: a comprehensive review of the literature
- 20k Downloads
Hundreds of genetic association studies on asthma-related phenotypes have been conducted in different populations. To date, variants in 64 genes have been reported to be associated with asthma or related traits in at least one study. Of these, 33 associations were replicated in a second study, 9 associations were not replicated either in a second study or a second sample in the same study, and 22 associations were reported in just a single published study. These results suggest the potential for a great amount of heterogeneity underlying asthma. However, many of these studies are methodologically limited and their interpretation hampered by small sample sizes.
KeywordsAsthma Linkage Disequilibrium Atopic Dermatitis Marker Allele Transmission Disequilibrium Test
List of abbreviations
- Alt a
- Amb a
Ambrosia artemisiifolia (short ragweed pollen)
- Bet v
Betula verucosa (birch pollen)
- Can f
Canis familiaris (dog allergen)
- Der p
Dermatophagoides pteronyssinus (house dust mite allergen)
false discovery rate
- Fel d
Felis domesticus (cat allergen)
forced exspiratory volume in the first second
forced vital capacity
house dust mite
- Lol p
Lolium perenne (rye grass pollen)
- Ole e
Olea Europaea (olive pollen)
- Par o
- Phl p
Phleum pratense (Timothy grass pollen)
single nucleotide polymorphism
skin prick test
radio allergo sorbent test
transmission disequilibrium test
Two general approaches have been widely used to study the genetics of asthma: genome-wide linkage studies followed by positional cloning and candidate gene association studies. The results of linkage studies for asthma have been described in detail elsewhere [1, 2, 3]; this review focuses on the published candidate gene association studies for asthma.
Candidate gene approach: basic principles and potential problems
"Candidate genes" are selected because their biological function suggests that they could play a role in the pathophysiology of asthma (such as genes encoding cytokines and their receptors, chemokines and their receptors, transcription factors, IgE receptor, etc.). Association studies between variation in these candidate genes and asthma-related phenotypes are mostly conducted in unrelated case and unrelated control samples by comparing allele or genotype frequencies between samples. Association studies with candidate genes are appealing because they are hypothesis-driven and can identify genetic variation that has relatively modest effects on susceptibility . Compared with linkage analysis, case-control studies are much simpler to perform and less costly because they do not require the collection of families. However, the interpretation of association studies is not always straightforward (for example, see ref. ). In particular, there are a large number of negative association studies with candidate genes that are never reported. Because the reported p-values are rarely adjusted for the total number of studies performed (both reported and unreported), the type I error rate in the reported studies is actually higher than the nominal level.
A statistically significant association between a variant in a candidate gene and a disease phenotype can have three possible explanations. (1) The marker allele truly affects gene function by altering the amino-acid sequence or by modifying splicing, transcriptional properties, or mRNA stability, and thereby directly affects disease risk. (2) The marker allele is in linkage disequilibrium (LD) with the true disease-causing variant. LD, or allelic association, is the nonrandom association of alleles at linked loci in populations, and will usually only be detected over small distances (≤ 60 approximated kb) [6, 7], although LD over longer distances has been observed. Thus, the marker allele must be located in relatively close proximity to the disease-causing variant. (3) The association is a false-positive result (type I error). Using a p-value of 0.05 as the threshold for significance will result in a 5% type I error rate. However, in most cases p-values are calculated using large sample approximations. As a result, the probability of type I errors for many of these approximations is higher than the nominal p-value when the sample size is small, as it is in most published studies. Further, false-positive results are more likely if multiple comparisons are made, either with multiple polymorphisms in the same gene, polymorphisms in multiple genes, or with multiple phenotypes. In these cases, the 5% false positive rate expected when the null hypothesis (of no association) is rejected at p < 0.05 no longer applies because there is a 5% type I error rate expected with each independent comparison (for example, with polymorphisms in different genes). A common correction for multiple comparisons is to multiply the p-values by the number of comparisons (known as a Bonferroni correction). Therefore, in a study of 10 variants, one would need to obtain a p-value of 0.005 to have the equivalent of a 5% type I error rate. However, the Bonferroni correction can be overly conservative if the multiple tests correspond to correlated variables. For example, phenotypes are often correlated (e.g., asthma and IgE levels) as are the genotypes of single nucleotide polymorphisms (SNPs) that are in LD. Thus, these comparisons do not represent independent tests and the Bonferroni correction can be extreme in these circumstances. In fact, the Bonferonni correction can be conservative even for independent tests . Because there is no simple correction for multiple correlated comparisons, alternative methods to correct for the error rates are used. Permutation tests are useful because they preserve the correlation structure of the data and provide accurate p-values. They can be used to control the probability of committing any type 1 error and this can lead to stringent thresholds in studies with a large number of candidate genes. An alternative approach is to control the False Discovery Rate (FDR) , which is the proportion of false positives in the set of rejected hypotheses. FDR is a more liberal rate to control, so it is more powerful.
Type I errors can also result from genotyping errors, particularly if there is a systematic error such as overcalling one genotype over another. This is particularly worrisome in case-control studies in unrelated individuals because Mendelian error checks cannot be performed as they can for family studies. One way to minimize this is to make sure that the genotypes in the cases and controls are in Hardy-Weinberg proportions. Systematic errors in genotyping will often yield genotype frequencies that are not in Hardy-Weinberg proportions. In fact, there are a surprisingly large number of published associations that either did not check for Hardy-Weinberg equilibrium or presented data that were not in Hardy-Weinberg proportions . When published association studies of a variety of diseases were re-examined, 12% of the 133 SNPs reported were not in Hardy-Weinberg equilibrium in the controls, suggesting genotyping error. Further, the proportion of SNPs that deviated from equilibrium was higher among the SNPs for which a positive association was reported . Some of these markers were not identified by the authors as showing deviations from equilibrium. One explanation for this could be that they used an incorrect test of significance, which may not be uncommon (e.g. [11, 12]). In particular, for a biallelic marker with three genotypes (such as for SNPs), the significance testing for Hardy-Weinberg equilibrium is based on a 1-degree of freedom test. On the other hand, markers showing departure from Hardy-Weinberg equilibrium should not be automatically discarded because deviation from Hardy-Weinberg equilibrium among cases is expected for variants close to a susceptibility locus under many genetic models [13, 14, 15]. Nevertheless, markers that show deviations from expectations should be closely scrutinized and retyped to ensure that they are genotyped correctly. Lastly, type I errors can result from population substructure, or sampling cases and controls that differ with respect to ethnic background. Because allele frequencies vary among ethnic groups, great care must be taken to assure that case and control subjects have similar ethnic compositions. If they differ, an allele may be significantly more frequent in the cases compared with controls due to differences in ethnicity, but this may be misinterpreted as an association with the disease. Methods are now available to directly test for stratification and to correct for any imbalances [16, 17], but these require genotyping the case and control samples for 30 or more informative loci (i.e., loci that discriminate between pairs of racial or ethnic groups ). Another approach to address the problem of population admixture is to conduct family-based association studies with analytical methods that are robust to population admixture, such as the transmission disequilibrium test (TDT) . These methods have become increasingly popular in genetic studies of complex disorders, although they are uniformly less powerful than studying an equivalent number of unrelated cases and controls.
Not all associations that are not replicated are false positive results. An association may not be replicated because of different patterns of LD in different populations. Differences in LD patterns can be caused by differences in allele frequencies and/or the presence of more than one causal variant. Although there are no examples of this, it remains a theoretical possibility. This can be addressed by examining haplotypes instead of single SNPs. Many studies have now shown that examining multiple SNPs as haplotypes is often preferable to single SNP analysis [19, 20]. A haplotype is composed of alleles at different loci that are inherited together on the same chromosome. Thus, even if the disease-causing variant itself is not identified, a shared haplotype that contains the disease variant will be more common in cases than in controls. This could in addition help to identify the true susceptibility variant. On the other hand, an association may not be replicated because the phenotype is defined differently between studies. For example, the phenotype "atopy" has been defined as a positive skin prick test [SPT], a positive RAST test, high total serum IgE, or a combination of these tests. Although these phenotypes are clearly related, it is likely that some genes that influence total IgE levels do not influence specific IgE response to allergens, and vice versa.
Lastly, positive associations may not be replicated because the true model of genetic susceptibility for diseases such as asthma and atopy is complex. It is most likely that any particular susceptibility variant has a relatively minor effect on the phenotype and that the magnitude of its effect will be influenced by genes at other loci (gene-gene interactions) [21, 22] and by the environmental factors (gene-environment interactions) [23, 24, 25]. In fact, some variants may only confer susceptibility in combination with other genes (epistasis) or in certain environments. Because background genes and environmental factors differ between populations it would not be surprising if associations with single SNPs or haplotypes differed between populations.
Review of the association study literature
We searched the public databases for published candidate gene association studies of asthma and related phenotypes, using keywords "association" or "case-control" together with each of the following: "asthma", "bronchial hyperresponsiveness", "BHR", "atopy", "SPT", "atopic dermatitis", "IgE", and "drug response". We identified 199 studies with at least one significant association reported. These studies identified 64 genes as potential susceptibility loci. We then searched for all other association studies with variants in these 64 genes (Table 1 [see Additional file 1]). For this analysis, we considered an initial association replicated if at least one other study found an association with variation in the same gene, but not necessarily with the same variant. Using these criteria, 33 gene associations were replicated and 9 associations were not replicated either in a second study or in a second sample in the same study. Additionally, 22 genetic associations were only reported in a single study, i.e. replication studies have not been published, even though it is likely that at least some have been performed. In this regard, the establishment of a database of non-significant candidate gene studies would helpful for prioritizing genes for genetic studies and would therefore benefit the asthma genetics community overall. Nonetheless, the results of this survey underline the potential for a great amount of heterogeneity underlying asthma. However, many of these studies have been conducted in small samples (<100 cases and controls), few correct for multiple testing, and in many cases, replication studies were performed in different ethnic groups than those studied in the original report. Lastly, in only 34.8 % of studies, all markers were reported to be in Hardy-Weinberg equilibrium, while in 2.2 % of studies at least one marker was reported to deviate from equilibrium, and in the majority of studies (63 %) testing for Hardy-Weinberg proportions was not mentioned at all.
Regardless of these caveats, some genes stand out because they were associated with asthma-phenotypes rather consistently across studies and populations. In particular, variation in eight genes have been associated with asthma-phenotypes in five or more studies: interleukin-4 (IL4), interleukin-13 (IL13), β2 adrenergic receptor (ADRB2), human leukocyte antigen DRB1 (HLA-DRB1), tumor necrosis factor (TNF), lymphotoxin-alpha (LTA), high-affinity IgE receptor (FCER1B) and IL-4 receptor (IL4RA). These loci likely represent true asthma or atopy susceptibility loci or genes important for disease modification. An example of the latter is the ADRB2 gene, which has been more consistently associated with asthma severity than with asthma or atopy per se.
Variants in 64 genes have been associated with asthma or atopy phenotypes in at least one study, although many of these studies are methodologically limited and need replication. In the future, association studies incorporating gene-gene and gene-environment interactions may help to disentangle some of the complexities of these diseases and explain some of the discrepant results. Lastly, the development of guidelines for establishing appropriate thresholds for significance in association studies would impose more rigorous standards on candidate gene studies, similar to what is now standard for linkage studies , and the creation of a database for unpublished association studies would be helpful for evaluating the overall evidence for association of asthma or atopy candidate genes.
The authors gratefully acknowledge Janette Coffey, April Chan and Susan Costello for clerical assistance. This work was supported in part by NIH grants HL56399, HL66533, HL70831, and HL72414; S.H. was supported in part by the Deutsche Forschungsgesellschaft.
- 8.Schwager SJ: Bonferroni sometimes loses. Am Stat 1984, 38:192–197.Google Scholar
- 9.Benjamini Y, Hochberg M: Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 1995, 57:289–300.Google Scholar
- 12.Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O'Leary VB, Parle-McDermott A, Scott JM, et al.: A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyvlohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 2002, 71:1207–1215.PubMedPubMedCentralCrossRefGoogle Scholar
- 14.Wittke JK, Cox NJ: Departures from Hardy-Weinberg equilibrium for common disease models. Am J Hum Genet 2003, 73S:620.Google Scholar
- 19.Ober C, Leavitt SA, Tsalenko A, Howard TD, Hoki DM, Daniel R, Newman DL, Wu X, Parry R, Lester LA, et al.: Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet 2000, 66:517–526.PubMedPubMedCentralCrossRefGoogle Scholar
- 20.Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB: Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000, 97:10483–10488.PubMedPubMedCentralCrossRefGoogle Scholar
- 30.Unoki M, Furuta S, Onouchi Y, Watanabe O, Doi S, Fujiwara H, Miyatake A, Fujita K, Tamari M, Nakamura Y: Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene. Hum Genet 2000, 106:440–446.PubMedCrossRefGoogle Scholar
- 31.Immervoll T, Loesgen S, Dutsch G, Gohlke H, Herbon N, Klugbauer S, Dempfle A, Bickeboller H, Becker-Follmann J, Ruschendorf F, et al.: Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes. Hum Mutat 2001, 18:327–336.PubMedCrossRefGoogle Scholar
- 32.Hakonarson H, Bjornsdottir US, Ostermann E, Arnason T, Adalsteinsdottir AE, Halapi E, Shkolny D, Kristjansson K, Gudnadottir SA, Frigge ML, et al.: Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med 2001, 164:2036–2044.PubMedCrossRefGoogle Scholar
- 56.Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ, Silverman EK, Martinez F, Weiss ST: Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies(small star, filled). Genomics 2003, 81:85–91.PubMedCrossRefGoogle Scholar
- 71.Takabayashi A, Ihara K, Sasaki Y, Suzuki Y, Nishima S, Izuhara K, Hamasaki N, Hara T: Childhood atopic asthma: positive association with a polymorphism of IL-4 receptor alpha gene but not with that of IL-4 promoter or Fc epsilon receptor I beta gene. Exp Clin Immunogenet 2000, 17:63–70.PubMedCrossRefGoogle Scholar
- 74.Tanaka K, Sugiura H, Uehara M, Hashimoto Y, Donnelly C, Montgomery DS: Lack of association between atopic eczema and the genetic variants of interleukin-4 and the interleukin-4 receptor alpha chain gene: heterogeneity of genetic backgrounds on immunoglobulin E production in atopic eczema patients. Clin Exp Allergy 2001, 31:1522–1527.PubMedCrossRefGoogle Scholar
- 75.Novak N, Kruse S, Kraft S, Geiger E, Kluken H, Fimmers R, Deichmann KA, Bieber T: Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol 2002, 119:870–875.PubMedCrossRefGoogle Scholar
- 77.Noguchi E, Nukaga-Nishio Y, Jian Z, Yokouchi Y, Kamioka M, Yamakawa-Kobayashi K, Hamaguchi H, Matsui A, Shibasaki M, Arinami T: Haplotypes of the 5' region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma. Hum Immunol 2001, 62:1251–1257.PubMedCrossRefGoogle Scholar
- 82.Liu X, Nickel R, Beyer K, Wahn U, Ehrlich E, Freidhoff LR, Bjorksten B, Beaty TH, Huang SK: An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol 2000, 106:167–170.PubMedCrossRefGoogle Scholar
- 83.Graves PE, Kabesch M, Halonen M, Holberg CJ, Baldini M, Fritzsch C, Weiland SK, Erickson RP, von Mutius E, Martinez FD: A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000, 105:506–513.PubMedCrossRefGoogle Scholar
- 97.Tsunemi Y, Saeki H, Nakamura K, Sekiya T, Hirai K, Fujita H, Asano N, Kishimoto M, Tanida Y, Kakinuma T, et al.: Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 2002, 30:161–166.PubMedCrossRefGoogle Scholar
- 98.Noguchi E, Yokouchi Y, Shibasaki M, Kamioka M, Yamakawa-Kobayashi K, Matsui A, Arinami T: Identification of missense mutation in the IL12B gene: lack of association between IL12B polymorphisms and asthma and allergic rhinitis in the Japanese population. Genes Immun 2001, 2:401–403.PubMedCrossRefGoogle Scholar
- 108.Lipworth BJ, Hall IP, Aziz I, Tan KS, Wheatley A: Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy. Clin Sci (Lond) 1999, 96:253–259.Google Scholar
- 111.Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, et al.: Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma. Int Arch Allergy Immunol 2001, 124:183–186.PubMedCrossRefGoogle Scholar
- 120.Van Sambeek R, Stevenson DD, Baldasaro M, Lam BK, Zhao J, Yoshida S, Yandora C, Drazen JM, Penrose JF: 5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol 2000, 106:72–76.PubMedCrossRefGoogle Scholar
- 122.Sayers I, Barton S, Rorke S, Beghe B, Hayward B, Van Eerdewegh P, Keith T, Clough JB, Ye S, Holloway JW, et al.: Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. Thorax 2003, 58:417–424.PubMedPubMedCentralCrossRefGoogle Scholar
- 124.Marsh DG, Hsu SH, Roebber M, Ehrlich-Kautzky E, Freidhoff LR, Meyers DA, Pollard MK, Bias WB: HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure. J Exp Med 1982, 155:1439–1451.PubMedCrossRefGoogle Scholar
- 129.Cardaba B, Vilches C, Martin E, de Andres B, del Pozo V, Hernandez D, Gallardo S, Fernandez JC, Villalba M, Rodriguez R, et al.: DR7 and DQ2 are positively associated with immunoglobulin-E response to the main antigen of olive pollen (Ole e I) in allergic patients. Hum Immunol 1993, 38:293–299.PubMedCrossRefGoogle Scholar
- 132.D'Amato M, Scotto d'Abusco A, Maggi E, Menna T, Sacerdoti G, Maurizio SM, Iozzino S, De Santo C, Oreste U, Tosi R, et al.: Association of responsiveness to the major pollen allergen of Parietaria officinalis with HLA-DRB1* alleles: a multicenter study. Hum Immunol 1996, 46:100–106.PubMedCrossRefGoogle Scholar
- 151.Lara-Marquez ML, Yunis JJ, Layrisse Z, Ortega F, Carvallo-Gil E, Montagnani S, Makhatadze NJ, Pocino M, Granja C, Yunis E: Immunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1*0301 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population. Clin Exp Allergy 1999, 29:60–71.PubMedCrossRefGoogle Scholar
- 165.El Bahlawan L, Christensen M, Binaei S, Murphy C, Zhang Q, Quasney M: Lack of association between the tumor necrosis factor-alpha regulatory region genetic polymorphisms associated with elevated tumor necrosis factor-alpha levels and children with asthma. Chest 2003, 123:374S-375S.PubMedCrossRefGoogle Scholar
- 173.Kruse S, Mao XQ, Heinzmann A, Blattmann S, Roberts MH, Braun S, Gao PS, Forster J, Kuehr J, Hopkin JM, et al.: The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma. Am J Hum Genet 2000, 66:1522–1530.PubMedPubMedCentralCrossRefGoogle Scholar
- 182.Tzetis M, Efthymiadou A, Strofalis S, Psychou P, Dimakou A, Pouliou E, Doudounakis S, Kanavakis E: CFTR gene mutations – including three novel nucleotide substitutions – and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet 2001, 108:216–221.PubMedCrossRefGoogle Scholar
- 191.In KH, Asano K, Beier D, Grobholz J, Finn PW, Silverman EK, Silverman ES, Collins T, Fischer AR, Keith TP, et al.: Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997, 99:1130–1137.PubMedPubMedCentralCrossRefGoogle Scholar
- 199.Sengler C, Heinzmann A, Jerkic SP, Haider A, Sommerfeld C, Niggemann B, Lau S, Forster J, Schuster A, Kamin W, et al.: Clara cell protein 16 (CC16) gene polymorphism influences the degree of airway responsiveness in asthmatic children. J Allergy Clin Immunol 2003, 111:515–519.PubMedCrossRefGoogle Scholar
- 206.Laprise C, Boulet LP, Morissette J, Winstall E, Raymond V: Evidence for association and linkage between atopy, airway hyper-responsiveness, and the beta subunit Glu237Gly variant of the high-affinity receptor for immunoglobulin E in the French-Canadian population. Immunogenetics 2000, 51:695–702.PubMedCrossRefGoogle Scholar
- 224.Noguchi E, Shibasaki M, Inudou M, Kamioka M, Yokouchi Y, Yamakawa-Kobayashi K, Hamaguchi H, Matsui A, Arinami T: Association between a new polymorphism in the activation-induced cytidine deaminase gene and atopic asthma and the regulation of total serum IgE levels. J Allergy Clin Immunol 2001, 108:382–386.PubMedCrossRefGoogle Scholar
- 232.Malerba G, Patuzzo C, Trabetti E, Lauciello MC, Galavotti R, Pescollderungg L, Whalen MB, Zanoni G, Martinati LC, Boner AL, et al.: Chromosome 14 linkage analysis and mutation study of 2 serpin genes in allergic asthmatic families. J Allergy Clin Immunol 2001, 107:654–658.PubMedCrossRefGoogle Scholar
- 240.Mujica-Lopez KI, Flores-Martinez SE, Ramos-Zepeda R, Castaneda-Ramos SA, Gazca-Aguilar A, Garcia-Perez J, Sanchez-Corona J: Association analysis of polymorphisms in the interleukin-4 receptor (alpha) gene with atopic asthma in patients from western Mexico. Eur J Immunogenet 2002, 29:375–378.PubMedCrossRefGoogle Scholar
- 251.Bottini N, Borgiani P, Otsu A, Saccucci P, Stefanini L, Greco E, Fontana L, Hopkin JM, Mao XQ, Shirakawa T: IL-4 receptor alpha chain genetic polymorphism and total IgE levels in the English population: two-locus haplotypes are more informative than individual SNPs. Clin Genet 2002, 61:288–292.PubMedCrossRefGoogle Scholar
- 265.Tsunemi Y, Saeki H, Nakamura K, Sekiya T, Hirai K, Fujita H, Asano N, Tanida Y, Kakinuma T, Wakugawa M, et al.: Eotaxin gene single nucleotide polymorphisms in the promoter and exon regions are not associated with susceptibility to atopic dermatitis, but two of them in the promoter region are associated with serum IgE levels in patients with atopic dermatitis. J Dermatol Sci 2002, 29:222–228.PubMedCrossRefGoogle Scholar
- 272.Leung TF, Tang NL, Lam CW, Li AM, Chan IH, Ha G: Thromboxane A2 receptor gene polymorphism is associated with the serum concentration of cat-specific immunoglobulin E as well as the development and severity of asthma in Chinese children. Pediatr Allergy Immunol 2002, 13:10–17.PubMedCrossRefGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.